Michael G. Lacey - Publications

Affiliations: 
Pharmacology University of Birmingham (United Kingdom) 

32/47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Lacey MG, Gooding-Williams G, Prokic EJ, Yamawaki N, Hall SD, Stanford IM, Woodhall GL. Spike firing and IPSPs in layer V pyramidal neurons during beta oscillations in rat primary motor cortex (M1) in vitro. Plos One. 9: e85109. PMID 24465488 DOI: 10.1371/Journal.Pone.0085109  0.606
2006 Wilson CL, Cash D, Galley K, Chapman H, Lacey MG, Stanford IM. Subthalamic nucleus neurones in slices from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mice show irregular, dopamine-reversible firing pattern changes, but without synchronous activity. Neuroscience. 143: 565-72. PMID 16973296 DOI: 10.1016/J.Neuroscience.2006.07.051  0.74
2005 Loucif KC, Wilson CL, Baig R, Lacey MG, Stanford IM. Functional interconnectivity between the globus pallidus and the subthalamic nucleus in the mouse brain slice. The Journal of Physiology. 567: 977-87. PMID 16037086 DOI: 10.1113/Jphysiol.2005.093807  0.728
2004 Wilson CL, Puntis M, Lacey MG. Overwhelmingly asynchronous firing of rat subthalamic nucleus neurones in brain slices provides little evidence for intrinsic interconnectivity. Neuroscience. 123: 187-200. PMID 14667453 DOI: 10.1016/J.Neuroscience.2003.09.008  0.589
2003 Tofighy A, Abbott A, Centonze D, Cooper AJ, Noor E, Pearce SM, Puntis M, Stanford IM, Wigmore MA, Lacey MG. Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology. Neuroscience. 116: 157-66. PMID 12535949 DOI: 10.1016/S0306-4522(02)00546-8  0.75
2001 Buckby LE, Lacey MG. Depression of excitatory cortico-nucleus accumbens synaptic transmission in rat brain slices by dopamine, but not adenosine, depends upon intracortical mechanisms. Experimental Brain Research. 141: 560-6. PMID 11810149 DOI: 10.1007/S00221-001-0927-2  0.525
2001 Buckby LE, Lacey MG. Epileptiform activity in the nucleus accumbens induced by GABA(A) receptor antagonists in rat forebrain slices is of cortical origin. Experimental Brain Research. 141: 146-52. PMID 11713626 DOI: 10.1007/s002210100841  0.41
2000 Wigmore MA, Lacey MG. A Kv3-like persistent, outwardly rectifying, Cs+-permeable, K+ current in rat subthalamic nucleus neurones. The Journal of Physiology. 527: 493-506. PMID 10990536 DOI: 10.1111/J.1469-7793.2000.T01-1-00493.X  0.461
1999 Chergui K, Lacey MG. Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432. Neuropharmacology. 38: 223-31. PMID 10218863 DOI: 10.1016/S0028-3908(98)00187-7  0.526
1998 Miyazaki T, Lacey MG. Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata. The Journal of Physiology. 513: 805-17. PMID 9824719 DOI: 10.1111/J.1469-7793.1998.805Ba.X  0.61
1998 Wigmore MA, Lacey MG. Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurones in vitro. British Journal of Pharmacology. 123: 667-74. PMID 9517386 DOI: 10.1038/Sj.Bjp.0701662  0.506
1997 Abbott A, Wigmore MA, Lacey MG. Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor. Brain Research. 766: 162-7. PMID 9359599 DOI: 10.1016/S0006-8993(97)00550-7  0.459
1997 Harvey J, Lacey MG. A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 5271-80. PMID 9204911 DOI: 10.1523/Jneurosci.17-14-05271.1997  0.705
1996 Stanford IM, Lacey MG. Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7566-73. PMID 8922413 DOI: 10.1523/Jneurosci.16-23-07566.1996  0.738
1996 Stanford IM, Lacey MG. Electrophysiological investigation of adenosine trisphosphate-sensitive potassium channels in the rat substantia nigra pars reticulata. Neuroscience. 74: 499-509. PMID 8865200 DOI: 10.1016/0306-4522(96)00151-0  0.728
1996 Harvey J, Lacey MG. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation. The Journal of Physiology. 492: 143-54. PMID 8730590 DOI: 10.1113/Jphysiol.1996.Sp021296  0.728
1995 Rick CE, Stanford IM, Lacey MG. Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors. Neuroscience. 69: 903-13. PMID 8596658 DOI: 10.1016/0306-4522(95)00283-O  0.766
1995 Stanford IM, Lacey MG. Regulation of a potassium conductance in rat midbrain dopamine neurons by intracellular adenosine triphosphate (ATP) and the sulfonylureas tolbutamide and glibenclamide. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 4651-7. PMID 7790930 DOI: 10.1523/Jneurosci.15-06-04651.1995  0.738
1994 Rick CE, Lacey MG. Rat substantia nigra pars reticulata neurones are tonically inhibited via GABAA, but not GABAB, receptors in vitro. Brain Research. 659: 133-7. PMID 7820654 DOI: 10.1016/0006-8993(94)90872-9  0.551
1993 Lacey MG. Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area Progress in Brain Research. 99: 251-276. PMID 7509080  0.357
1992 Häusser MA, Yung WH, Lacey MG. Taurine and glycine activate the same Cl- conductance in substantia nigra dopamine neurones. Brain Research. 571: 103-8. PMID 1611483 DOI: 10.1016/0006-8993(92)90514-A  0.471
1991 Seabrook GR, Howson W, Lacey MG. Subpopulations of GABA-mediated synaptic potentials in slices of rat dorsal striatum are differentially modulated by presynaptic GABAB receptors. Brain Research. 562: 332-4. PMID 1663417  0.426
1991 Seabrook GR, Evans ML, Howson W, Benham CD, Lacey MG. Presynaptic inhibition mediated by GABA(B) receptors in rat striatal brain slices Annals of the New York Academy of Sciences. 635: 495-496. PMID 1660253  0.349
1990 Lacey MG, Mercuri NB, North RA. Actions of cocaine on rat dopaminergic neurones in vitro. British Journal of Pharmacology. 99: 731-5. PMID 2361170 DOI: 10.1111/J.1476-5381.1990.Tb12998.X  0.683
1990 Lacey MG, Calabresi P, North RA. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. The Journal of Pharmacology and Experimental Therapeutics. 253: 395-400. PMID 2329522  0.631
1990 Seabrook GR, Howson W, Lacey MG. Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices. British Journal of Pharmacology. 101: 949-57. PMID 1964824  0.401
1989 Calabresi P, Lacey MG, North RA. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. British Journal of Pharmacology. 98: 135-40. PMID 2804543  0.584
1989 Lacey MG, Mercuri NB, North RA. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 1233-41. PMID 2703874 DOI: 10.1523/Jneurosci.09-04-01233.1989  0.701
1989 Lacey M, Mercuri N, North R. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids The Journal of Neuroscience. 9: 1233-1241. DOI: 10.1523/JNEUROSCI.09-04-01233.1989  0.5
1988 Lacey MG, Mercuri NB, North RA. On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. The Journal of Physiology. 401: 437-53. PMID 2459376 DOI: 10.1113/Jphysiol.1988.Sp017171  0.711
1987 McFadzean I, Lacey MG, Hill RG, Henderson G. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro Neuroscience. 20: 231-239. PMID 3031541 DOI: 10.1016/0306-4522(87)90015-7  0.384
1987 Lacey MG, Mercuri NB, North RA. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. The Journal of Physiology. 392: 397-416. PMID 2451725 DOI: 10.1113/Jphysiol.1987.Sp016787  0.709
Low-probability matches (unlikely to be authored by this person)
1986 Lacey MG, Henderson G. Actions of phencyclidine on rat locus coeruleus neurones in vitro Neuroscience. 17: 485-494. PMID 3517691 DOI: 10.1016/0306-4522(86)90261-7  0.288
1984 Lacey MG, Henderson G. Electrophysiological analysis of kappa opiate receptor activation in the rabbit vas deferens Neuropeptides. 5: 257-260. PMID 6152325 DOI: 10.1016/0143-4179(84)90076-3  0.236
1996 Wigmore M, Abbott A, Lacey M. Functional characterisation of mGluRs in ventral midbrain Neuropharmacology. 35: A33. DOI: 10.1016/0028-3908(96)84779-4  0.236
2005 Lacey M, Bohday J, Fonseka SM, Ullah AI, Whitehead SA. Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. The Journal of Steroid Biochemistry and Molecular Biology. 96: 279-86. PMID 16023337 DOI: 10.1016/j.jsbmb.2005.03.006  0.208
2009 Anastasius N, Boston S, Lacey M, Storing N, Whitehead SA. Evidence that low-dose, long-term genistein treatment inhibits oestradiol-stimulated growth in MCF-7 cells by down-regulation of the PI3-kinase/Akt signalling pathway. The Journal of Steroid Biochemistry and Molecular Biology. 116: 50-5. PMID 19406242 DOI: 10.1016/j.jsbmb.2009.04.009  0.122
2010 Jawaid K, Crane SR, Nowers JL, Lacey M, Whitehead SA. Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 120: 164-71. PMID 20399854 DOI: 10.1016/j.jsbmb.2010.04.007  0.095
2018 Lacey M, Chandra S, Tzianetas R, Arcand J. Evaluation of actions, barriers, and facilitators to reducing dietary sodium in health care institutions. Food Science & Nutrition. 6: 2337-2343. PMID 30510733 DOI: 10.1002/fsn3.814  0.092
2002 Whitehead SA, Cross JE, Burden C, Lacey M. Acute and chronic effects of genistein, tyrphostin and lavendustin A on steroid synthesis in luteinized human granulosa cells Human Reproduction. 17: 589-594. PMID 11870108  0.088
2013 Panjabi S, Lacey M, Bancroft T, Cao F. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients. Journal of the American Society of Hypertension : Jash. 7: 46-60. PMID 23321404 DOI: 10.1016/j.jash.2012.11.001  0.087
2012 Burton TM, Lacey M, Liu F, Yu Y, Monsalvo ML, Lang K, Sander S. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel. Journal of Medical Economics. 15: 1217-25. PMID 22857539 DOI: 10.3111/13696998.2012.718020  0.037
2015 Lacey M, Jayaram MB. Zuclopenthixol versus placebo for schizophrenia. The Cochrane Database of Systematic Reviews. 12: CD010598. PMID 26624987 DOI: 10.1002/14651858.CD010598.pub2  0.015
2017 McMurray JJV, Trueman D, Hancock E, Cowie MR, Briggs A, Taylor M, Mumby-Croft J, Woodcock F, Lacey M, Haroun R, Deschaseaux C. Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. Heart (British Cardiac Society). PMID 29269379 DOI: 10.1136/Heartjnl-2016-310661  0.015
2004 Halpern MT, Lacey M, Clark MA, Valentin MA. Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents. Bmc Cardiovascular Disorders. 4: 23. PMID 15596004 DOI: 10.1186/1471-2261-4-23  0.014
2013 Deitelzweig SB, Pinsky B, Buysman E, Lacey M, Makenbaeva D, Wiederkehr D, Graham J. Bleeding as an outcome among patients with nonvalvular atrial fibrillation in a large managed care population. Clinical Therapeutics. 35: 1536-45.e1. PMID 24075151 DOI: 10.1016/j.clinthera.2013.08.013  0.01
2013 Deitelzweig SB, Buysman E, Pinsky B, Lacey M, Jing Y, Wiederkehr D, Graham J. Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population. Clinical Therapeutics. 35: 1201-10. PMID 23867114 DOI: 10.1016/j.clinthera.2013.06.005  0.01
Hide low-probability matches.